{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker&_page=0", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker", "items" : [{"_about" : "http://data.parliament.uk/resources/1719284", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1719284/answer", "answerText" : {"_value" : "
We are aware of supply issues with three pancreatic enzyme replacement therapies: Creon 10,000 gastro-resistant capsules; Creon 25,000 gastro-resistant capsules; and Nutrizym 22 gastro-resistant capsules. We understand that these are due to limited availability of active pharmaceutical ingredients, and manufacturing constraints in producing the volumes required to meet demand. The Department has issued guidance to healthcare professionals regarding treatment of patients while there is a disruption to the supply of these pancreatic enzyme replacement therapies. We are having regular conversations with the suppliers of these products to ask that they expedite deliveries and increase production forecasts, and to confirm that they are taking action to address the root causes of the issues, to ensure continuity of supply. We are also working with specialist importers to source unlicensed imports from abroad.<\/p>
Whilst we can\u2019t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-05-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-23T15:24:29.583Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-20", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pancreatic Enzyme Replacement Therapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps she is taking to help ensure the adequacy of access to (a) Creon and (b) other drugs that contain pancreatic enzymes for patients after pancreatic surgery.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"} } , "tablingMemberConstituency" : {"_value" : "Broxbourne"} , "tablingMemberPrinted" : [{"_value" : "Sir Charles Walker"} ], "uin" : "26982"} , {"_about" : "http://data.parliament.uk/resources/1717955", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717955/answer", "answerText" : {"_value" : "
My Rt hon. Friend, the Secretary of State for Health and Social Care has written to Royal Mail regarding proposed reforms to the universal postal service, to ask what consideration has been given to patients and National Health Service impacts. A meeting with the Group Chief Executive of Royal Mail is currently being considered.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-05-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-17T07:39:59.09Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Correspondence"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if she will hold discussions with Royal Mail on the potential merits of treating NHS letters as first class post, in the context of possible reforms to the second class delivery service.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"} } , "tablingMemberConstituency" : {"_value" : "Broxbourne"} , "tablingMemberPrinted" : [{"_value" : "Sir Charles Walker"} ], "uin" : "26093"} , {"_about" : "http://data.parliament.uk/resources/1717956", "AnsweringBody" : [{"_value" : "Department for Levelling Up, Housing and Communities"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717956/answer", "answerText" : {"_value" : "
Landlords are required by law to protect a deposit in relation to most Assured Shorthold Tenancies and are free to choose with which government-authorised scheme they protect a tenant\u2019s deposit.<\/p>
The TDP providers are private companies that are operationally independent of Government. TDP providers are contractually obliged to avoid any conflict of interest arising which prejudices the independence and objectivity of the service provided.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4825", "label" : {"_value" : "Biography information for Jacob Young"} } , "answeringMemberConstituency" : {"_value" : "Redcar"} , "answeringMemberPrinted" : {"_value" : "Jacob Young"} , "dateOfAnswer" : {"_value" : "2024-05-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-17T12:37:14.863Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "211"} , "answeringDeptShortName" : {"_value" : "Levelling Up, Housing and Communities"} , "answeringDeptSortName" : {"_value" : "Levelling Up, Housing and Communities"} , "date" : {"_value" : "2024-05-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Tenancy Deposit Schemes"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Levelling Up, Housing and Communities, if he will make an assessment of the potential implications for his policies of potential conflicts of interest in circumstances where the board members of deposit protection schemes are also landlords who choose to lodge deposits with the same scheme; and if he will make it his policy to require landlords to lodge deposits with deposit protection schemes with which they have no governance involvement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"} } , "tablingMemberConstituency" : {"_value" : "Broxbourne"} , "tablingMemberPrinted" : [{"_value" : "Sir Charles Walker"} ], "uin" : "26094"} , {"_about" : "http://data.parliament.uk/resources/1717957", "AnsweringBody" : [{"_value" : "Ministry of Justice"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717957/answer", "answerText" : {"_value" : "
HMCTS remains focused on increasing outputs to reduce overall timeliness on all types of applications. Management information published by HMCTS shows the average mean length of time taken for a grant of probate (following receipt of the documents required) reduced by 3 weeks in March 2024 compared to February 2024. The average timeliness in March was 9 weeks.<\/p>
The first quarter of 2024 (January to March 2024) saw the highest quarterly number of grants issued on record.<\/p>
<\/p>
A full time series of Official Statistics back to Q3 2019 is published in the Family Court Statistics Quarterly https://www.gov.uk/government/collections/family-court-statistics-quarterly<\/a> and currently covers the period up to December 2023.<\/p>
Financial Year<\/p><\/td> | Funding amount<\/p><\/td><\/tr> |
2018/19<\/p><\/td> | £2.9 million<\/p><\/td><\/tr> |
2019/20<\/p><\/td> | £150,000<\/p><\/td><\/tr> |
2020/21<\/p><\/td> | £2.2 million<\/p><\/td><\/tr> |
2021/22<\/p><\/td> | £5.3 million<\/p><\/td><\/tr> |
2022/23<\/p><\/td> | £750,000<\/p><\/td><\/tr> |
Total<\/p><\/td> | £11.3 million<\/p><\/td><\/tr><\/tbody><\/table> Note: the amount of funding awarded will differ to actual spend in a given year, as total spending will include that of multi-year awards made in previous years.<\/p> The NIHR funds research in response to proposals received from scientists, rather than allocating funding to specific disease areas. It is not usual practice to ring-fence funds for particular topics or conditions. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.<\/p> To increase the quality, diversity, and number of brain cancer research proposals, the NIHR is working with the Tessa Jowell Brain Cancer Mission and the research community, to develop research capacity in the brain cancer community.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2024-04-03", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1692165/answer/previousversion/20891", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} } , "questionFirstAnswered" : [{"_value" : "2024-04-03T15:17:18.357Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-02-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Brain: Tumours"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the level of NHS funding for brain tumour research compared to research into other cancers; and if she will provide the quantum of NHS research funding into brain tumours for each of the last five financial years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"} } , "tablingMemberConstituency" : {"_value" : "Broxbourne"} , "tablingMemberPrinted" : [{"_value" : "Sir Charles Walker"} ], "uin" : "15848"} , {"_about" : "http://data.parliament.uk/resources/1688164", "AnsweringBody" : [{"_value" : "Department for Education"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1688164/answer", "answerText" : {"_value" : " The government does not collect the specific information requested. The legal responsibility for providing free home-to-school travel for eligible pupils sits with local authorities, who will hold any data available on the amount spent on taxis for children with an Education, Health and Care plan.<\/p> However, the government does publish local authority expenditure data based on Section 251 outturn returns, which includes total expenditure on home-to-school travel for children of compulsory school age where the travel is agreed for reasons of the child\u2019s Special Educational Needs and Disabilities. Local authorities spent a total of £1.25 billion in the 2022/23 financial year on this type of home-to-school travel. The data is available via the following link: https://explore-education-statistics.service.gov.uk/find-statistics/la-and-school-expenditure<\/a>.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3969", "label" : {"_value" : "Biography information for Damian Hinds"} } , "answeringMemberConstituency" : {"_value" : "East Hampshire"} , "answeringMemberPrinted" : {"_value" : "Damian Hinds"} , "dateOfAnswer" : {"_value" : "2024-02-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-02-19T13:22:42.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "60"} , "answeringDeptShortName" : {"_value" : "Education"} , "answeringDeptSortName" : {"_value" : "Education"} , "date" : {"_value" : "2024-02-07", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Special Educational Needs: Transport"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Education, whether her Department collects data on the amount spent by local authorities on taxis used to transport children with an education, health and care plan to and from school.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1493", "label" : {"_value" : "Biography information for Sir Charles Walker"} } , "tablingMemberConstituency" : {"_value" : "Broxbourne"} , "tablingMemberPrinted" : [{"_value" : "Sir Charles Walker"} ], "uin" : "13537"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Sir+Charles+Walker&_page=1", "page" : 0, "startIndex" : 1, "totalResults" : 409, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} } |